List of Tables
Table 1. Global Brucellosis Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Brucellosis Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Brucellosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Brucellosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Brucellosis Treatment Market Share by Region (2018-2023)
Table 8. Global Brucellosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Brucellosis Treatment Market Share by Region (2024-2029)
Table 10. Brucellosis Treatment Market Trends
Table 11. Brucellosis Treatment Market Drivers
Table 12. Brucellosis Treatment Market Challenges
Table 13. Brucellosis Treatment Market Restraints
Table 14. Global Brucellosis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Brucellosis Treatment Revenue Share by Players (2018-2023)
Table 16. Global Top Brucellosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Treatment as of 2022)
Table 17. Global Brucellosis Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Brucellosis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Brucellosis Treatment, Headquarters and Area Served
Table 20. Global Key Players of Brucellosis Treatment, Product and Application
Table 21. Global Key Players of Brucellosis Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Brucellosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Brucellosis Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Brucellosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Brucellosis Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Brucellosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Brucellosis Treatment Revenue Share by Application (2018-2023)
Table 29. Global Brucellosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Brucellosis Treatment Revenue Share by Application (2024-2029)
Table 31. North America Brucellosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Brucellosis Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Brucellosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Brucellosis Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Brucellosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Brucellosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Brucellosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Brucellosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Brucellosis Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Brucellosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Brucellosis Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Brucellosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Brucellosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Brucellosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Brucellosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Brucellosis Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Brucellosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Brucellosis Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Brucellosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Brucellosis Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Brucellosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Brucellosis Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Brucellosis Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Brucellosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Brucellosis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Brucellosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Brucellosis Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Brucellosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Brucellosis Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Brucellosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Brucellosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Brucellosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 63. Pfizer Inc. Company Details
Table 64. Pfizer Inc. Business Overview
Table 65. Pfizer Inc. Brucellosis Treatment Product
Table 66. Pfizer Inc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 67. Pfizer Inc. Recent Developments
Table 68. Bayer Company Details
Table 69. Bayer Business Overview
Table 70. Bayer Brucellosis Treatment Product
Table 71. Bayer Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 72. Bayer Recent Developments
Table 73. Huvepharma Company Details
Table 74. Huvepharma Business Overview
Table 75. Huvepharma Brucellosis Treatment Product
Table 76. Huvepharma Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 77. Huvepharma Recent Developments
Table 78. OraPharma,Inc. Company Details
Table 79. OraPharma,Inc. Business Overview
Table 80. OraPharma,Inc. Brucellosis Treatment Product
Table 81. OraPharma,Inc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 82. OraPharma,Inc. Recent Developments
Table 83. Merck & Co.Inc. Company Details
Table 84. Merck & Co.Inc. Business Overview
Table 85. Merck & Co.Inc. Brucellosis Treatment Product
Table 86. Merck & Co.Inc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 87. Merck & Co.Inc. Recent Developments
Table 88. RempexPharmaceuticals,Inc. Company Details
Table 89. RempexPharmaceuticals,Inc. Business Overview
Table 90. RempexPharmaceuticals,Inc. Brucellosis Treatment Product
Table 91. RempexPharmaceuticals,Inc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 92. RempexPharmaceuticals,Inc. Recent Developments
Table 93. ZeotisInc. Company Details
Table 94. ZeotisInc. Business Overview
Table 95. ZeotisInc. Brucellosis Treatment Product
Table 96. ZeotisInc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 97. ZeotisInc. Recent Developments
Table 98. BoehringerIngelheim International GmbH. Company Details
Table 99. BoehringerIngelheim International GmbH. Business Overview
Table 100. BoehringerIngelheim International GmbH. Brucellosis Treatment Product
Table 101. BoehringerIngelheim International GmbH. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 102. BoehringerIngelheim International GmbH. Recent Developments
Table 103. Elanco Company Details
Table 104. Elanco Business Overview
Table 105. Elanco Brucellosis Treatment Product
Table 106. Elanco Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 107. Elanco Recent Developments
Table 108. Virabc Inc. Company Details
Table 109. Virabc Inc. Business Overview
Table 110. Virabc Inc. Brucellosis Treatment Product
Table 111. Virabc Inc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 112. Virabc Inc. Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brucellosis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Brucellosis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global Brucellosis Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Brucellosis Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Brucellosis Treatment Report Years Considered
Figure 11. Global Brucellosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Brucellosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Brucellosis Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Brucellosis Treatment Market Share by Players in 2022
Figure 15. Global Top Brucellosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Brucellosis Treatment Revenue in 2022
Figure 17. North America Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Brucellosis Treatment Market Share by Type (2018-2029)
Figure 19. North America Brucellosis Treatment Market Share by Application (2018-2029)
Figure 20. North America Brucellosis Treatment Market Share by Country (2018-2029)
Figure 21. United States Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Brucellosis Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Brucellosis Treatment Market Share by Type (2018-2029)
Figure 25. Europe Brucellosis Treatment Market Share by Application (2018-2029)
Figure 26. Europe Brucellosis Treatment Market Share by Country (2018-2029)
Figure 27. Germany Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Brucellosis Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Brucellosis Treatment Market Share by Type (2018-2029)
Figure 35. China Brucellosis Treatment Market Share by Application (2018-2029)
Figure 36. Asia Brucellosis Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Brucellosis Treatment Market Share by Type (2018-2029)
Figure 38. Asia Brucellosis Treatment Market Share by Application (2018-2029)
Figure 39. Asia Brucellosis Treatment Market Share by Region (2018-2029)
Figure 40. Japan Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Brucellosis Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Brucellosis Treatment Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Brucellosis Treatment Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Brucellosis Treatment Market Share by Country (2018-2029)
Figure 50. Brazil Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Pfizer Inc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 57. Bayer Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 58. Huvepharma Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 59. OraPharma,Inc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 60. Merck & Co.Inc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 61. RempexPharmaceuticals,Inc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 62. ZeotisInc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 63. BoehringerIngelheim International GmbH. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 64. Elanco Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 65. Virabc Inc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed